 | • レポートコード：GIR201100182 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、アシネトバクター感染症治療の世界市場を調査対象にし、アシネトバクター感染症治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（スルバクタム、カルバペネム、アミノグリコシド、ポリミキシン、テトラサイクリン、その他）、用途別分析（ETX2514、ナクバクタムRG6080、アレニシン、VXD-001、低分子抗生物質、AR-401 mAB、LCB01-0371（PO）、GN-4474、抗菌抗体）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Entasis Therapeutics、Atterx Biotherapeutics、Vaxdyn、Roche、LegoChem Biosciences、Adenium Biotech、Peptilogics、Aridis Pharmaceuticals、Hsiri Therapeutics、Achaogen、Sealife PHARMA、Tetraphase Pharmaceuticals、Shionogi、Techulon ・メーカー別販売量、売上、市場シェア ・アシネトバクター感染症治療の地域別市場分析 ・アシネトバクター感染症治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・アシネトバクター感染症治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・アシネトバクター感染症治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・アシネトバクター感染症治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・アシネトバクター感染症治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・アシネトバクター感染症治療の種類別市場規模2015-2020：スルバクタム、カルバペネム、アミノグリコシド、ポリミキシン、テトラサイクリン、その他 ・アシネトバクター感染症治療の用途別市場規模2015-2020：ETX2514、ナクバクタムRG6080、アレニシン、VXD-001、低分子抗生物質、AR-401 mAB、LCB01-0371（PO）、GN-4474、抗菌抗体 ・アシネトバクター感染症治療の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Acinetobacter Infections Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Acinetobacter Infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Acinetobacter Infections Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Acinetobacter Infections Treatment market has been segmented into
Sulbactam
Carbapenems
Aminoglycosides
Polymyxins
Tetracyclines
Others
By Application, Acinetobacter Infections Treatment has been segmented into:
ETX2514
Nacubactam RG6080
Arenicin
VXD-001
Small molecule antibiotic
AR-401 mAB
LCB01-0371 (PO)
GN-4474
Antibacterial Antibody
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acinetobacter Infections Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Acinetobacter Infections Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acinetobacter Infections Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Acinetobacter Infections Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Acinetobacter Infections Treatment Market Share Analysis
Acinetobacter Infections Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Acinetobacter Infections Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Acinetobacter Infections Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Acinetobacter Infections Treatment are:
Entasis Therapeutics
Atterx Biotherapeutics
Vaxdyn
Roche
LegoChem Biosciences
Adenium Biotech
Peptilogics
Aridis Pharmaceuticals
Hsiri Therapeutics
Achaogen
Sealife PHARMA
Tetraphase Pharmaceuticals
Shionogi
Techulon
Among other players domestic and global, Acinetobacter Infections Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Acinetobacter Infections Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Acinetobacter Infections Treatment, with price, sales, revenue and global market share of Acinetobacter Infections Treatment in 2018 and 2019.
Chapter 3, the Acinetobacter Infections Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Acinetobacter Infections Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Acinetobacter Infections Treatment market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Acinetobacter Infections Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Acinetobacter Infections Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Acinetobacter Infections Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Sulbactam
1.2.3 Carbapenems
1.2.4 Aminoglycosides
1.2.5 Polymyxins
1.2.6 Tetracyclines
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Acinetobacter Infections Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 ETX2514
1.3.3 Nacubactam RG6080
1.3.4 Arenicin
1.3.5 VXD-001
1.3.6 Small molecule antibiotic
1.3.7 AR-401 mAB
1.3.8 LCB01-0371 (PO)
1.3.9 GN-4474
1.3.10 Antibacterial Antibody
1.4 Overview of Global Acinetobacter Infections Treatment Market
1.4.1 Global Acinetobacter Infections Treatment Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Entasis Therapeutics
2.1.1 Entasis Therapeutics Details
2.1.2 Entasis Therapeutics Major Business
2.1.3 Entasis Therapeutics SWOT Analysis
2.1.4 Entasis Therapeutics Product and Services
2.1.5 Entasis Therapeutics Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Atterx Biotherapeutics
2.2.1 Atterx Biotherapeutics Details
2.2.2 Atterx Biotherapeutics Major Business
2.2.3 Atterx Biotherapeutics SWOT Analysis
2.2.4 Atterx Biotherapeutics Product and Services
2.2.5 Atterx Biotherapeutics Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Vaxdyn
2.3.1 Vaxdyn Details
2.3.2 Vaxdyn Major Business
2.3.3 Vaxdyn SWOT Analysis
2.3.4 Vaxdyn Product and Services
2.3.5 Vaxdyn Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 LegoChem Biosciences
2.5.1 LegoChem Biosciences Details
2.5.2 LegoChem Biosciences Major Business
2.5.3 LegoChem Biosciences SWOT Analysis
2.5.4 LegoChem Biosciences Product and Services
2.5.5 LegoChem Biosciences Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Adenium Biotech
2.6.1 Adenium Biotech Details
2.6.2 Adenium Biotech Major Business
2.6.3 Adenium Biotech Product and Services
2.6.4 Adenium Biotech Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Peptilogics
2.7.1 Peptilogics Details
2.7.2 Peptilogics Major Business
2.7.3 Peptilogics Product and Services
2.7.4 Peptilogics Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Aridis Pharmaceuticals
2.8.1 Aridis Pharmaceuticals Details
2.8.2 Aridis Pharmaceuticals Major Business
2.8.3 Aridis Pharmaceuticals Product and Services
2.8.4 Aridis Pharmaceuticals Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Hsiri Therapeutics
2.9.1 Hsiri Therapeutics Details
2.9.2 Hsiri Therapeutics Major Business
2.9.3 Hsiri Therapeutics Product and Services
2.9.4 Hsiri Therapeutics Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Achaogen
2.10.1 Achaogen Details
2.10.2 Achaogen Major Business
2.10.3 Achaogen Product and Services
2.10.4 Achaogen Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sealife PHARMA
2.11.1 Sealife PHARMA Details
2.11.2 Sealife PHARMA Major Business
2.11.3 Sealife PHARMA Product and Services
2.11.4 Sealife PHARMA Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Tetraphase Pharmaceuticals
2.12.1 Tetraphase Pharmaceuticals Details
2.12.2 Tetraphase Pharmaceuticals Major Business
2.12.3 Tetraphase Pharmaceuticals Product and Services
2.12.4 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Shionogi
2.13.1 Shionogi Details
2.13.2 Shionogi Major Business
2.13.3 Shionogi Product and Services
2.13.4 Shionogi Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Techulon
2.14.1 Techulon Details
2.14.2 Techulon Major Business
2.14.3 Techulon Product and Services
2.14.4 Techulon Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Acinetobacter Infections Treatment Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Acinetobacter Infections Treatment Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Acinetobacter Infections Treatment Manufacturer Market Share in 2019
3.3.2 Top 6 Acinetobacter Infections Treatment Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Acinetobacter Infections Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Acinetobacter Infections Treatment Sales and Market Share by Regions (2015-2020)
4.1.2 Global Acinetobacter Infections Treatment Revenue and Market Share by Regions (2015-2020)
4.2 North America Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
4.3 Europe Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
4.5 South America Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Acinetobacter Infections Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Acinetobacter Infections Treatment Sales and Market Share by Country (2015-2020)
5.1.2 North America Acinetobacter Infections Treatment Revenue and Market Share by Country (2015-2020)
5.2 United States Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
5.3 Canada Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
5.4 Mexico Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Acinetobacter Infections Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe Acinetobacter Infections Treatment Sales and Market Share by Country (2015-2020)
6.1.2 Europe Acinetobacter Infections Treatment Revenue and Market Share by Country (2015-2020)
6.2 Germany Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
6.3 UK Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
6.4 France Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
6.5 Russia Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
6.6 Italy Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Acinetobacter Infections Treatment Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Acinetobacter Infections Treatment Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Acinetobacter Infections Treatment Revenue and Market Share by Regions (2015-2020)
7.2 China Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
7.3 Japan Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
7.4 Korea Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
7.5 India Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
7.7 Australia Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Acinetobacter Infections Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Acinetobacter Infections Treatment Sales and Market Share by Country (2015-2020)
8.1.2 South America Acinetobacter Infections Treatment Revenue and Market Share by Country (2015-2020)
8.2 Brazil Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
8.3 Argentina Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Acinetobacter Infections Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Acinetobacter Infections Treatment Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Acinetobacter Infections Treatment Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
9.3 Turkey Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
9.4 Egypt Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
9.5 South Africa Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Acinetobacter Infections Treatment Sales and Market Share by Type (2015-2020)
10.2 Global Acinetobacter Infections Treatment Revenue and Market Share by Type (2015-2020)
10.3 Global Acinetobacter Infections Treatment Price by Type (2015-2020)
11 Global Acinetobacter Infections Treatment Market Segment by Application
11.1 Global Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
11.2 Global Acinetobacter Infections Treatment Revenue Market Share by Application (2015-2020)
11.3 Global Acinetobacter Infections Treatment Price by Application (2015-2020)
12 Market Forecast
12.1 Global Acinetobacter Infections Treatment Sales, Revenue and Growth Rate (2021-2025)
12.2 Acinetobacter Infections Treatment Market Forecast by Regions (2021-2025)
12.2.1 North America Acinetobacter Infections Treatment Market Forecast (2021-2025)
12.2.2 Europe Acinetobacter Infections Treatment Market Forecast (2021-2025)
12.2.3 Asia-Pacific Acinetobacter Infections Treatment Market Forecast (2021-2025)
12.2.4 South America Acinetobacter Infections Treatment Market Forecast (2021-2025)
12.2.5 Middle East & Africa Acinetobacter Infections Treatment Market Forecast (2021-2025)
12.3 Acinetobacter Infections Treatment Market Forecast by Type (2021-2025)
12.3.1 Global Acinetobacter Infections Treatment Sales Forecast by Type (2021-2025)
12.3.2 Global Acinetobacter Infections Treatment Market Share Forecast by Type (2021-2025)
12.4 Acinetobacter Infections Treatment Market Forecast by Application (2021-2025)
12.4.1 Global Acinetobacter Infections Treatment Sales Forecast by Application (2021-2025)
12.4.2 Global Acinetobacter Infections Treatment Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Acinetobacter Infections Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Acinetobacter Infections Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Acinetobacter Infections Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Acinetobacter Infections Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Entasis Therapeutics Basic Information, Manufacturing Base and Competitors
Table 9. Entasis Therapeutics Acinetobacter Infections Treatment Major Business
Table 10. Entasis Therapeutics Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 11. Entasis Therapeutics SWOT Analysis
Table 12. Entasis Therapeutics Acinetobacter Infections Treatment Product and Services
Table 13. Entasis Therapeutics Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Atterx Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 15. Atterx Biotherapeutics Acinetobacter Infections Treatment Major Business
Table 16. Atterx Biotherapeutics Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 17. Atterx Biotherapeutics SWOT Analysis
Table 18. Atterx Biotherapeutics Acinetobacter Infections Treatment Product and Services
Table 19. Atterx Biotherapeutics Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Vaxdyn Basic Information, Manufacturing Base and Competitors
Table 21. Vaxdyn Acinetobacter Infections Treatment Major Business
Table 22. Vaxdyn Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 23. Vaxdyn SWOT Analysis
Table 24. Vaxdyn Acinetobacter Infections Treatment Product and Services
Table 25. Vaxdyn Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Roche Basic Information, Manufacturing Base and Competitors
Table 27. Roche Acinetobacter Infections Treatment Major Business
Table 28. Roche Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 29. Roche SWOT Analysis
Table 30. Roche Acinetobacter Infections Treatment Product and Services
Table 31. Roche Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. LegoChem Biosciences Basic Information, Manufacturing Base and Competitors
Table 33. LegoChem Biosciences Acinetobacter Infections Treatment Major Business
Table 34. LegoChem Biosciences Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 35. LegoChem Biosciences SWOT Analysis
Table 36. LegoChem Biosciences Acinetobacter Infections Treatment Product and Services
Table 37. LegoChem Biosciences Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Adenium Biotech Basic Information, Manufacturing Base and Competitors
Table 39. Adenium Biotech Acinetobacter Infections Treatment Major Business
Table 40. Adenium Biotech Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 41. Adenium Biotech SWOT Analysis
Table 42. Adenium Biotech Acinetobacter Infections Treatment Product and Services
Table 43. Adenium Biotech Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Peptilogics Basic Information, Manufacturing Base and Competitors
Table 45. Peptilogics Acinetobacter Infections Treatment Major Business
Table 46. Peptilogics Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 47. Peptilogics SWOT Analysis
Table 48. Peptilogics Acinetobacter Infections Treatment Product and Services
Table 49. Peptilogics Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Aridis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 51. Aridis Pharmaceuticals Acinetobacter Infections Treatment Major Business
Table 52. Aridis Pharmaceuticals Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 53. Aridis Pharmaceuticals SWOT Analysis
Table 54. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product and Services
Table 55. Aridis Pharmaceuticals Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Hsiri Therapeutics Basic Information, Manufacturing Base and Competitors
Table 57. Hsiri Therapeutics Acinetobacter Infections Treatment Major Business
Table 58. Hsiri Therapeutics Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 59. Hsiri Therapeutics SWOT Analysis
Table 60. Hsiri Therapeutics Acinetobacter Infections Treatment Product and Services
Table 61. Hsiri Therapeutics Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Achaogen Basic Information, Manufacturing Base and Competitors
Table 63. Achaogen Acinetobacter Infections Treatment Major Business
Table 64. Achaogen Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 65. Achaogen SWOT Analysis
Table 66. Achaogen Acinetobacter Infections Treatment Product and Services
Table 67. Achaogen Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Sealife PHARMA Basic Information, Manufacturing Base and Competitors
Table 69. Sealife PHARMA Acinetobacter Infections Treatment Major Business
Table 70. Sealife PHARMA Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 71. Sealife PHARMA SWOT Analysis
Table 72. Sealife PHARMA Acinetobacter Infections Treatment Product and Services
Table 73. Sealife PHARMA Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Tetraphase Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 75. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Major Business
Table 76. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 77. Tetraphase Pharmaceuticals SWOT Analysis
Table 78. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product and Services
Table 79. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Shionogi Basic Information, Manufacturing Base and Competitors
Table 81. Shionogi Acinetobacter Infections Treatment Major Business
Table 82. Shionogi Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 83. Shionogi SWOT Analysis
Table 84. Shionogi Acinetobacter Infections Treatment Product and Services
Table 85. Shionogi Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Techulon Basic Information, Manufacturing Base and Competitors
Table 87. Techulon Acinetobacter Infections Treatment Major Business
Table 88. Techulon Acinetobacter Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 89. Techulon SWOT Analysis
Table 90. Techulon Acinetobacter Infections Treatment Product and Services
Table 91. Techulon Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Global Acinetobacter Infections Treatment Sales by Manufacturer (2018-2019) (Cases)
Table 93. Global Acinetobacter Infections Treatment Revenue by Manufacturer (2018-2019) (USD Million)
Table 94. Global Acinetobacter Infections Treatment Sales by Regions (2015-2020) (Cases)
Table 95. Global Acinetobacter Infections Treatment Sales Market Share by Regions (2015-2020)
Table 96. Global Acinetobacter Infections Treatment Revenue by Regions (2015-2020) (USD Million)
Table 97. North America Acinetobacter Infections Treatment Sales by Countries (2015-2020) (Cases)
Table 98. North America Acinetobacter Infections Treatment Sales Market Share by Countries (2015-2020)
Table 99. North America Acinetobacter Infections Treatment Revenue by Countries (2015-2020) (USD Million)
Table 100. North America Acinetobacter Infections Treatment Revenue Market Share by Countries (2015-2020)
Table 101. Europe Acinetobacter Infections Treatment Sales by Countries (2015-2020) (Cases)
Table 102. Europe Acinetobacter Infections Treatment Sales Market Share by Countries (2015-2020)
Table 103. Europe Acinetobacter Infections Treatment Revenue by Countries (2015-2020) (USD Million)
Table 104. Asia-Pacific Acinetobacter Infections Treatment Sales by Regions (2015-2020) (Cases)
Table 105. Asia-Pacific Acinetobacter Infections Treatment Sales Market Share by Regions (2015-2020)
Table 106. Asia-Pacific Acinetobacter Infections Treatment Revenue by Regions (2015-2020) (USD Million)
Table 107. South America Acinetobacter Infections Treatment Sales by Countries (2015-2020) (Cases)
Table 108. South America Acinetobacter Infections Treatment Sales Market Share by Countries (2015-2020)
Table 109. South America Acinetobacter Infections Treatment Revenue by Countries (2015-2020) (USD Million)
Table 110. South America Acinetobacter Infections Treatment Revenue Market Share by Countries (2015-2020)
Table 111. Middle East & Africa Acinetobacter Infections Treatment Sales by Countries (2015-2020) (Cases)
Table 112. Middle East & Africa Acinetobacter Infections Treatment Sales Market Share by Countries (2015-2020)
Table 113. Middle East & Africa Acinetobacter Infections Treatment Revenue by Countries (2015-2020) (USD Million)
Table 114. Middle East & Africa Acinetobacter Infections Treatment Revenue Market Share by Countries (2015-2020)
Table 115. Global Acinetobacter Infections Treatment Sales by Type (2015-2020) (Cases)
Table 116. Global Acinetobacter Infections Treatment Sales Share by Type (2015-2020)
Table 117. Global Acinetobacter Infections Treatment Revenue by Type (2015-2020) (USD Million)
Table 118. Global Acinetobacter Infections Treatment Revenue Share by Type (2015-2020)
Table 119. Global Acinetobacter Infections Treatment Sales by Application (2015-2020) (Cases)
Table 120. Global Acinetobacter Infections Treatment Sales Share by Application (2015-2020)
Table 121. Global Acinetobacter Infections Treatment Sales Forecast by Regions (2021-2025) (Cases)
Table 122. Global Acinetobacter Infections Treatment Market Share Forecast by Regions (2021-2025)
Table 123. Global Acinetobacter Infections Treatment Sales Forecast by Type (2021-2025) (Cases)
Table 124. Global Acinetobacter Infections Treatment Market Share Forecast by Type (2021-2025)
Table 125. Global Acinetobacter Infections Treatment Sales Forecast by Application (2021-2025)
Table 126. Global Acinetobacter Infections Treatment Market Share Forecast by Application (2021-2025)
Table 127. Direct Channel Pros & Cons
Table 128. Indirect Channel Pros & Cons
Table 129. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Acinetobacter Infections Treatment Picture
Figure 2. Global Sales Market Share of Acinetobacter Infections Treatment by Type in 2019
Figure 3. Sulbactam Picture
Figure 4. Carbapenems Picture
Figure 5. Aminoglycosides Picture
Figure 6. Polymyxins Picture
Figure 7. Tetracyclines Picture
Figure 8. Others Picture
Figure 9. Acinetobacter Infections Treatment Sales Market Share by Application in 2019
Figure 10. ETX2514 Picture
Figure 11. Nacubactam RG6080 Picture
Figure 12. Arenicin Picture
Figure 13. VXD-001 Picture
Figure 14. Small molecule antibiotic Picture
Figure 15. AR-401 mAB Picture
Figure 16. LCB01-0371 (PO) Picture
Figure 17. GN-4474 Picture
Figure 18. Antibacterial Antibody Picture
Figure 19. Global Acinetobacter Infections Treatment Market Status and Outlook (2015-2025) (USD Million)
Figure 20. United States Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Canada Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Mexico Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Germany Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 24. France Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 25. UK Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Russia Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Italy Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 28. China Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Japan Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Korea Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 31. India Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Southeast Asia Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Australia Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 34. Brazil Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Egypt Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Saudi Arabia Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 37. South Africa Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 38. Turkey Acinetobacter Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 39. Global Acinetobacter Infections Treatment Sales Market Share by Manufacturer in 2019
Figure 40. Global Acinetobacter Infections Treatment Revenue Market Share by Manufacturer in 2019
Figure 41. Top 3 Acinetobacter Infections Treatment Manufacturer (Revenue) Market Share in 2019
Figure 42. Top 6 Acinetobacter Infections Treatment Manufacturer (Revenue) Market Share in 2019
Figure 43. Key Manufacturer Market Share Trend
Figure 44. Global Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 45. Global Acinetobacter Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. Global Acinetobacter Infections Treatment Revenue Market Share by Regions (2015-2020)
Figure 47. Global Acinetobacter Infections Treatment Revenue Market Share by Regions in 2018
Figure 48. North America Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
Figure 49. Europe Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
Figure 50. Asia-Pacific Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
Figure 51. South America Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
Figure 52. Middle East & Africa Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020)
Figure 53. North America Acinetobacter Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. North America Acinetobacter Infections Treatment Sales Market Share by Countries (2015-2020)
Figure 55. North America Acinetobacter Infections Treatment Sales Market Share by Countries in 2018
Figure 56. North America Acinetobacter Infections Treatment Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 57. North America Acinetobacter Infections Treatment Revenue Market Share by Countries in 2018
Figure 58. United States Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 59. Canada Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 60. Mexico Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 61. Europe Acinetobacter Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Europe Acinetobacter Infections Treatment Revenue Market Share by Countries (2015-2020)
Figure 63. Europe Acinetobacter Infections Treatment Revenue Market Share by Countries in 2019
Figure 64. Germany Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 65. UK Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 66. France Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 67. Russia Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 68. Italy Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 69. Asia-Pacific Acinetobacter Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. Asia-Pacific Acinetobacter Infections Treatment Sales Market Share by Regions 2019
Figure 71. Asia-Pacific Acinetobacter Infections Treatment Revenue Market Share by Regions 2019
Figure 72. China Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 73. Japan Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 74. Korea Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 75. India Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 76. Southeast Asia Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 77. South America Acinetobacter Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. South America Acinetobacter Infections Treatment Sales Market Share by Countries in 2019
Figure 79. South America Acinetobacter Infections Treatment Revenue Market Share by Countries in 2019
Figure 80. Brazil Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 81. Argentina Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 82. Middle East and Africa Acinetobacter Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 83. Middle East and Africa Acinetobacter Infections Treatment Sales Market Share by Countries in 2019
Figure 84. Middle East and Africa Acinetobacter Infections Treatment Revenue Market Share by Countries (2015-2020)
Figure 85. Middle East and Africa Acinetobacter Infections Treatment Revenue Market Share by Countries in 2019
Figure 86. Saudi Arabia Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 87. Egypt Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 88. Turkey Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 89. South Africa Acinetobacter Infections Treatment Sales and Growth Rate (2015-2020) (Cases)
Figure 90. Global Acinetobacter Infections Treatment Sales and Growth Rate (2021-2025) (Cases)
Figure 91. Global Acinetobacter Infections Treatment Revenue and Growth Rate (2021-2025) (USD Million)
Figure 92. North America Sales Acinetobacter Infections Treatment Market Forecast (2021-2025) (Cases)
Figure 93. Europe Sales Acinetobacter Infections Treatment Market Forecast (2021-2025) (Cases)
Figure 94. Asia-Pacific Sales Acinetobacter Infections Treatment Market Forecast (2021-2025) (Cases)
Figure 95. South America Sales Acinetobacter Infections Treatment Market Forecast (2021-2025) (Cases)
Figure 96. Middle East & Africa Sales Acinetobacter Infections Treatment Market Forecast (2021-2025) (Cases)
Figure 97. Sales Channel: Direct Channel vs Indirect Channel
人工関節感染症（PJI）治療の世界市場 2020年 Market Overview The global Prosthetic Joint Infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prosthe…- 壊死性皮膚感染症治療の世界市場 2020年 Market Overview The global Necrotizing Skin infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Necroti…
- ナイセリア淋病感染症治療の世界市場 2020年 Market Overview The global Neisseria Gonorrhoeae Infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ne…
- エプスタインバーウイルス（HHV-4）感染症治療の世界市場 2020年 Market Overview The global Epstein-Barr Virus (HHV-4) Infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…
- 髄膜炎菌感染症ワクチンの世界市場 2020年 Market Overview The global Meningococcal Infections Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meningococca…